HLTH 4530 Week 11 Population Choice Paper Example

Many Modest Gains or a Few Visible Rescues: Why a Regional Health Authority Should Fund Population Blood Pressure Control Over a Specialty Unit for Pulmonary Arterial Hypertension, and What the Unit Would Have Bought

Student Name

Walden University

HLTH 4530: Healthcare Economics From a Population Health Perspective

Instructor Name

Month Day, Year

Many Modest Gains or a Few Visible Rescues: Why a Regional Health Authority Should Fund Population Blood Pressure Control Over a Specialty Unit for Pulmonary Arterial Hypertension, and What the Unit Would Have Bought

The Choice

The Northgate Regional Health Authority, a composite public body serving about 900,000 people, has one fixed allocation for new services next year and two proposals, each of which would use all of it. The first is a population blood pressure control program: community health workers and pharmacists would find adults with uncontrolled hypertension in clinics, pharmacies, barbershops and workplaces, and manage their treatment under agreements with their physicians. The second is a specialty unit for pulmonary arterial hypertension, a rare and serious disease of the lung arteries, which would bring expert diagnosis, costly targeted medicines and close monitoring to the region's patients, who now travel several hours to a distant center. The authority can fund one. This paper argues that it should fund the blood pressure program.

Option 1: Population Blood Pressure Control

High blood pressure is common, often untreated or undertreated and a leading cause of strokes, kidney failure, heart attacks and heart failure. Its consequences are spread across thousands of people, most of whom will never know that treatment prevented their stroke.

The evidence that lowering blood pressure prevents these events is strong. A meta-analysis of 123 trials with 613,815 participants found that every 10 mm Hg reduction in systolic blood pressure reduced the risk of major cardiovascular events by about 20%, stroke by about 27% and heart failure by about 28%, and all-cause mortality by 13% (Ettehad et al., 2016).

Community delivery can produce large reductions. In Los Angeles County, a cluster-randomized trial covering 52 barbershops with Black owners found that men with uncontrolled hypertension whose barbers referred them to specialty-trained pharmacists, who prescribed medicines in the shop, lowered their systolic pressure by 27.0 mm Hg over six months, against 9.3 mm Hg in an active control group, and 63.6% reached a pressure below 130/80 mm Hg compared with 11.7% of controls (Victor et al., 2018). Northgate's program would adapt that model across several community settings.

Option 2: A Specialty Unit for Pulmonary Arterial Hypertension

Pulmonary arterial hypertension is rare. Northgate's planners estimate that a few dozen residents have it at any time. Without specialist care, it progresses to right heart failure, and its patients are often young adults. Targeted therapies can improve exercise capacity and slow progression, but they are expensive, and expert centers are needed to diagnose the disease accurately and manage treatment.

A local unit would spare these patients long journeys, catch the disease earlier and give them continuity of care. Its benefits would be concentrated and visible: each patient helped would be a known person, often with a family that has campaigned for exactly this unit.

The Argument: More Health for the Same Money

The core argument rests on two ideas from earlier in this course. The first is opportunity cost. The allocation spent on one option is the value of the other forgone. Funding the specialty unit would mean forgoing the blood pressure control that the same money could buy for thousands of adults.

The second is cost-effectiveness reasoning. Although no local estimate of cost per quality-adjusted life year is available for either option, and this paper does not invent one, the structure of the two options points one way. The blood pressure program delivers a modest benefit to each of a very large number of people, with strong trial evidence that the benefit translates into fewer strokes and heart attacks. The specialty unit delivers a larger benefit to each of a small number of people at a high cost per patient, dominated by medicine prices.

Rose (1985) pointed out that most cases of a common disease arise among the many people whose risk is only moderately raised rather than among the few at the extreme, so nudging everyone's risk down a little can avert more events than treating only those at the top. Blood pressure is the classic example. On that reasoning, the population program is likely to produce more health for the region than the unit, even though no individual's benefit will be as dramatic.

The Rule of Rescue

The specialty unit will have stronger public support, and that pull is a serious moral consideration, not a bias to be explained away. Jonsen (1986) coined the term "rule of rescue" for the imperative people feel to save identifiable individuals facing avoidable death, whatever the cost. McKie and Richardson (2003) describe how the rule conflicts with cost-effectiveness analysis: it favors identifiable over statistical lives and life-saving over other measures, and it produces a "shock-horror" response when an identifiable person is denied help. They also argue that the rule can be defended, because rescues reinforce people's belief that they live in a community that cares for its members, which is itself a social good.

That defense is real, and it counts in the unit's favor. A region that turns away patients with a rare, fatal disease sends a message about how it values its members. But the people whose strokes the blood pressure program would prevent are also real; they are only harder to name. Choosing the visible rescue over the larger number of invisible ones treats the second group's lives as worth less simply because no one knows in advance who they are.

What the Unit Would Have Bought

The decision has a cost, and it should be stated plainly. Without the unit, Northgate's patients with pulmonary arterial hypertension will continue to travel for care. Some will be diagnosed later than they would have been. Some will miss appointments because the journey is too hard, and for some of those patients the disease will advance faster than it would have with local care. Families who campaigned for the unit will be disappointed, and their disappointment is legitimate.

The authority can reduce this cost without funding the full unit. It can pay for travel and lodging for patients attending the distant center, set up telehealth follow-up with that center's specialists and train one local physician to share care. These measures cost a small fraction of the unit and keep the region's commitment to these patients visible.

Conclusion

Northgate should fund the population blood pressure program because it is likely to produce more health for the region's fixed budget, preventing many cardiovascular events among people who will never know they were helped. The rule of rescue is a real moral consideration and argues for doing what is affordable for patients with the rare disease, but it does not justify forgoing the larger gain. The authority should make the choice openly, explain it to the families affected and revisit it when the next allocation is made.

References

Ettehad, D., Emdin, C. A., Kiran, A., Anderson, S. G., Callender, T., Emberson, J., Chalmers, J., Rodgers, A., & Rahimi, K. (2016). Blood pressure lowering for prevention of cardiovascular disease and death: A systematic review and meta-analysis. The Lancet, 387(10022), 957-967. https://doi.org/10.1016/S0140-6736(15)01225-8

Jonsen, A. R. (1986). Bentham in a box: Technology assessment and health care allocation. Law, Medicine and Health Care, 14(3-4), 172-174. https://doi.org/10.1111/j.1748-720X.1986.tb00974.x

McKie, J., & Richardson, J. (2003). The rule of rescue. Social Science & Medicine, 56(12), 2407-2419. https://doi.org/10.1016/S0277-9536(02)00244-7

Rose, G. (1985). Sick individuals and sick populations. International Journal of Epidemiology, 14(1), 32-38. https://doi.org/10.1093/ije/14.1.32

Victor, R. G., Lynch, K., Li, N., Blyler, C., Muhammad, E., Handler, J., Brettler, J., Rashid, M., Hsu, B., Foxx-Drew, D., Moy, N., Reid, A. E., & Elashoff, R. M. (2018). A cluster-randomized trial of blood-pressure reduction in Black barbershops. New England Journal of Medicine, 378(14), 1291-1301. https://doi.org/10.1056/NEJMoa1717250